Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced
Latest available record · 8 Oct 2026

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

Published by 2 Nov 2025
Drag the red line through time · ← → a day · Shift+← → a week. Later days aren’t drawn: they haven’t been published yet.
816not yet publishedAug 25Sep 25Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26

Scope · likely financings by canton

37 likely financings · 4 Oct 2025 – 2 Nov 2025 · the feed below shows one weekClick a canton to filter the feedMap: Natural Earth

Likely financing
Looks like new money from outside investors: Claude, reading the entry and the rule signals, scores it 0.60 or higher.
Undecided
Some financing signals, not enough to call it: a score from 0.35 to below 0.60, or no usable score.
Capital increased
No sign of a financing round: the pre-filter found nothing to send to Claude, or Claude scored it below 0.35. Typical causes are converted loans, assets contributed in kind, reserves turned into capital or a conversion to an AG.
Confirmed round
A financing announcement on startupticker.ch names the company and matches this increase.

Published 27 Oct – 2 Nov 2025

44 capital increases · 10 shown
Showing: likely financings and confirmed rounds ▾
Show
Capital increases published 27 Oct – 2 Nov 2025
CompanyStatusNominal share capital (CHF)
before → after		New shares, % of
post-step shares		Announced roundnot disclosed in the SHABSHAB publishedSource
Invenda Group AGOW · Die Gesellschaft bezweckt die Planung, die Entwicklung, die Produktion, den Unterhalt, den Handel und den …SHAB publication HR02-1006472255Likely financingscore 0.80514’956 → 764’018New shares 32.6%32.6%—31 Oct 2025SHAB publication HR02-1006472255
Exnaton AGZH · Die Gesellschaft bezweckt die Erbringung von Dienstleistungen in den Bereichen Software, Digitalisierung, …SHAB publication HR02-1006471913Confirmed roundscore 0.96Announced round: Announced ↗189’521.33 → 259’713.17New shares 27.0%27.0%Announced ↗31 Oct 2025SHAB publication HR02-1006471913
HemostOD SAVD · la société a pour but la recherche, le développement, la fabrication et la production de technologies …SHAB publication HR02-1006471607Likely financing · possible confirmationscore 0.80211’494.61 → 229’539.84New shares 7.9%7.9%—30 Oct 2025SHAB publication HR02-1006471607
UMANITEK AGZG · Die Gesellschaft bezweckt die Erbringung von Dienstleistungen aller Art, insbesondere die Beratung im …SHAB publication HR02-1006471188Likely financingscore 0.65105’000 → 115’318.10New shares 8.9%8.9%—30 Oct 2025SHAB publication HR02-1006471188
SANTERSUS AGZH · Der Zweck der Gesellschaft ist die Beratung, Forschung und Produktentwicklung im Bereich der biomedizinischen …SHAB publication HR02-1006470840Likely financingscore 0.85216’449 → 221’968.50New shares 2.5%2.5%—30 Oct 2025SHAB publication HR02-1006470840
QUMEA AGSO · Entwicklung, Produktion, Vertrieb, Lizenzausgabe von und Handel mit elektronischen Produkten, Geräten und …SHAB publication HR02-1006470148Confirmed roundscore 0.93Announced round: Announced ↗769’600.98 → 1’019’638.52New shares 24.5%24.5%Announced ↗29 Oct 2025SHAB publication HR02-1006470148
K2 Photonics AGZH · Die Gesellschaft bezweckt die Entwicklung und den Vertrieb von Lasersystemen und Komponenten optischer …SHAB publication HR02-1006469704Likely financingscore 0.95100’000 → 135’252.30New shares 26.1%26.1%—29 Oct 2025SHAB publication HR02-1006469704
InnoMedica Holding AGZG · Die Gesellschaft bezweckt das Halten, den Kauf, Verkauf sowie die Verwaltung von Beteiligungen an (kotierten …SHAB publication HR02-1006468887Likely financingscore 0.601’599’880.80 → 1’905’303.40New shares 16.0%16.0%—28 Oct 2025SHAB publication HR02-1006468887
PreComb Therapeutics AGZH · Die Gesellschaft bezweckt die Forschung, Entwicklung und den Vertrieb von pharmazeutischen, biologischen, …SHAB publication HR02-1006468509Likely financingscore 0.82352’561.50 → 402’209.10New shares 12.3%12.3%—28 Oct 2025SHAB publication HR02-1006468509
Porters Group AGZH · Die Gesellschaft bezweckt die Entwicklung, Produktion, Lizenzierung und den Vertrieb von technologischen …SHAB publication HR02-1006467368Likely financingscore 0.90118’685.46 → 125’604.24New shares 5.5%5.5%—27 Oct 2025SHAB publication HR02-1006467368

34 other capital increases published this week ▸